The Evaluation the Relationship Between LAG-3 Expression / Immune Checkpoint Protein Expression and Neoadjuvant Chemotherapy Plus Immune Checkpoint Inhibitor in Triple Negative Breast Cancer
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study is the experimental study for relationship between LAG-3 expression / immue checkpoint protein expression and neoadjuvant chemotherapy plus immune checkpoint inhibitor in triple negative breast cancer.
Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: t
View:
• Planned neoadjuvant chemotherapy
• Triple negative breast cancer
Locations
Other Locations
Republic of Korea
Ji-Yeon Kim
RECRUITING
Seoul
Contact Information
Primary
Ji-Yeon Kim
jyeon25@skku.edu
82-2-3410-3459
Backup
Mee Ryung Hong
ring7629@naver.com
82-2-2148-7147
Time Frame
Start Date: 2022-11-18
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 128
Treatments
Experimental: LAG-3 expression/immune checkpoint protein expression evaluation
Related Therapeutic Areas
Sponsors
Leads: Samsung Medical Center